Cognetix, Inc.

COGNETIX

Pharmaceutical research and development services for others; drug discovery, namely, pharmaceutical drug development services for others; scientific research for others, namely, chemical identification and drug target identification and characterization; laboratory research for others in the field of pharmaceuticals; diagnostic services, namely, medical laboratory services;

COGNETIX

Licensing of technology and equipment used in the development and manufacture of pharmaceuticals; promoting the pharmaceutical products of others in promotional materials and by providing a website identifying the manufactures of these products;

CONO-CHEM

Biochemicals, namely polypeptides for scientific or research use;Development of new technology for others in the field of Biochemistry; Scientific support, namely providing peptides for the medical and research use of others; Diagnostic services in the field of Biochemistry; Technical consultation in the field of Biochemistry;

CONOGENETIX

Pharmaceutical preparations for the treatment of central and peripheral nervous system disorders, neurological disorders, cardiovascular and cerebrovascular disorders, neuromuscular discords, and demyelinating disorders, namely pain states, including acute and chronic pain, post-operative pain, neuropathic pain, inflammatory pain, and cancer pain; myocardial infarction, arrhythmia, heart failure, and stroke; multiple sclerosis; spinal cord injury; epilepsy; cancer; chemotherapy-induced nausea and vomiting;schizophrenia, depression, bipolar disorder, autism, attention deficit disorder, and addition; Alzheimer's disease and Parkinson's disease; traumatic head injury; and spasticity;

CONOGENETIX

Diagnostic reagents for scientific or research use; assays for identification of chemicals for use in the identification of and treatment of disorders and diseases for scientific or research use and therapeutic development;